gms | German Medical Science

66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Friendship Meeting mit der Italienischen Gesellschaft für Neurochirurgie (SINch)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

7. - 10. Juni 2015, Karlsruhe

Stereotactic radiofrequency thermocoagulation as alternative treatment option in focal epilepsy

Meeting Abstract

Suche in Medline nach

  • Yaroslav Parpaley - Klinik für Neurochirurgie
  • Marec von Lehe - Klinik für Neurochirurgie
  • Jörg Wellmer - Ruhr-Epileptologie, Universitätsklinikum Knappschaftskrankenhaus Bochum
  • Jürgen Voges - Universitätsklinik für Stereotaktische Neurochirurgie Otto-von Guericke-Universität, Magdeburg; Leibniz Institut für Neurobiologie, Magdeburg

Deutsche Gesellschaft für Neurochirurgie. 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Karlsruhe, 07.-10.06.2015. Düsseldorf: German Medical Science GMS Publishing House; 2015. DocMI.05.06

doi: 10.3205/15dgnc280, urn:nbn:de:0183-15dgnc2807

Veröffentlicht: 2. Juni 2015

© 2015 Parpaley et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: Modern imaging and improvements in invasive diagnostic of epilepsies allow detection of small epileptogenic lesions, also deep seated or eloquent. Surgical removal of them, even if providing good seizure outcome, can be problematic and risky. Stereotactic radiofrequency thermocoagulation (SRT) allows targeted destruction of small deep or eloquent seated lesions with minimal collateral damage to brain tissue. We report results of SRT in 8 patients.

Method: 8 patients, treated with SRT since 2011 (6 patients with focal cortical dysplasia, 1 patient with histologically unclear lesion and 1 patient with hypothalamic hamartoma (HH)) received multifocal MR- based and SEEG-tailored SRT. In three cases we predicted two independent active irritative zones, in these we decided to perform SRT in SEEG-verified seizure onset zone. SRT was done using multifokal radiofrequency destruction through stereotactic 2,1 mm lesioning electrode. Resulting lesion was consisting of multiple (up to 7) trajectories with several lesions on each, summary SRT volume covered MRI-defined volume of lesion. We recorded SEEG from each lesioning point and from locations, surrounding defined lesion volume on planed trajectories. In several cases we detected specific epileptogenic activity outside of predefined treatment volume and we expended lesions to include these highly active spots.

Results: Complete seizure freedom was archived in 3 patients with focal cortical dysplasia. In 2 Patients with highly active irritative zones in basal temporal lobe and lesions in lingual gyrus we archived >90% seizure reduction. In one patient with complex insular focal dysplasia due to incomplete lesion was no seizure reduction observed. In 2 Patients (eloquent FCD and HH) due to short postoperative follow-up no seizure outcome yet available. One patient developed permanent incomplete expressive aphasia after treatment. No further permanent morbidity or complications observed.

Conclusions: Seizure freedom can be achieved using SRT lesioning in patients with lesional epilepsy. In patients with multiple independent epileptogenic zones it is possible to use SRT as low risk technique resulting in seizure reduction or even seizure freedom also as palliative treatment. Further evaluations of required lesioning volume extension in relation to MRI target volume and SEEG profile are needed. To predict exact lesioning result of multifocal SRT further research of radiofrequency lesion pathophysiology and physics in brain tissue necessary.